JAMA+ AI Conversations

Retinal images are becoming powerful windows into human health. Cecilia Lee, MD, MS, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen to explore how AI-enhanced imaging reveals early disease signals, leverages large datasets, and shifts clinical practice in ophthalmology.

Related Content:
Insights From the Eye With AI

AI chatbots have advanced rapidly, incorporating new reasoning architectures that reshape decision-making and medical education. Jonathan Chen, MD, PhD, and Ethan Goh, MD, MS, of Stanford University join JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the latest generation of AI models, the importance of evaluating benefits and harms, and sycophancy in AI systems.

Related Content:
Multiple Reasoning Models and the Future of AI Chatbots
AI Chatbots in Clinical Practice
Large Language Model Influence on Diagnostic Reasoning

JAMA+ AI Editor in Chief Roy Perlis and Associate Editor Yulin Hswen discuss some of the most cited AI papers in 2025 across the JAMA Network. A little bit of gen AI, some prediction models, and deep learning from videos as well as an increasing awareness of the challenges of real-world deployment.

Related Content:
AI and Health—The Year in Review

How can AI systems reason safely in the open world of medicine? JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, talks with Eric Horvitz, MD, PhD, Chief Scientific Officer at Microsoft, about the future of AI in 5 years to 100 years, from neurons to the nebulous, and how we can guide AI to be copilots while maintaining integrity and safety in the clinical arena.

Related Content:
AI—Days of Future Past

Will AI usher in a new era of rapid drug discovery? In this episode of JAMA+ AI Conversations, Editor in Chief Roy Perlis interviews Ajamete Kaykas, Chief eXploration Officer at Insitro, a biotech company looking to apply AI to develop new therapeutics.

Related Content:
AI in the Lab—Will It Really Change Drug Discovery?